IBRX Stock-Based Compensation
Immunitybio Inc · Stock-Based Compensation
IBRX Stock-Based Compensation
Latest reported$34.31Mperiod ending
IBRX Stock-Based Comp ($0.00 → $34.31M)
Annual stock-based compensation
High-resolution chart · PNG
IBRX stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 36,809,000 | |
| 34,432,000 | |
| 49,163,000 | |
| 40,179,000 | |
| 57,181,000 | |
| 2,187,000 | |
| 3,421,000 | |
| 2,043,000 | |
| 36,997,000 | |
| 73,852,000 | |
| 211,221,000 | |
| 0 | |
| 0 |